TY  - GEN
AU  - Fondevila, Marcos F
AU  - Novoa, Eva
AU  - Gonzalez-Rellan, Maria J
AU  - Fernandez, Uxia
AU  - Heras, Violeta
AU  - Porteiro, Begoña
AU  - Parracho, Tamara
AU  - Dorta, Valentina
AU  - Riobello, Cristina
AU  - da Silva Lima, Natalia
AU  - Seoane, Samuel
AU  - Garcia-Vence, Maria
AU  - Chantada-Vazquez, Maria P
AU  - Bravo, Susana-Belén
AU  - Senra, Ana
AU  - Leiva, Magdalena
AU  - Marcos, Miguel
AU  - Sabio, Guadalupe
AU  - Perez-Fernandez, Roman
AU  - Dieguez, Carlos
AU  - Prevot, Vincent
AU  - Schwaninger, Markus
AU  - Woodhoo, Ashwin
AU  - Martinez-Chantar, Maria L
AU  - Schwabe, Robert
AU  - Cubero, Francisco J
AU  - Varela-Rey, Marta
AU  - Crespo, Javier
AU  - Iruzubieta, Paula
AU  - Nogueiras, Ruben
PY  - 2024
DO  - 10.1016/j.xcrm.2024.101401
UR  - http://hdl.handle.net/20.500.12105/20037
AB  - The p63 protein has pleiotropic functions and, in the liver, participates in the progression of nonalcoholic fatty liver disease (NAFLD). However, its functions in hepatic stellate cells (HSCs) have not yet been explored. TAp63 is induced in HSCs from...
LA  - eng
PB  - Elsevier
KW  - Hepatic Stellate Cells
KW  - Non-alcoholic Fatty Liver Disease
KW  - Humans
KW  - Mice
KW  - Animals
KW  - Activation, Metabolic
KW  - Liver Cirrhosis
KW  - Fibrosis
KW  - Acetyl-CoA Carboxylase
TI  - p63 controls metabolic activation of hepatic stellate cells and fibrosis via an HER2-ACC1 pathway.
TY  - research article
ER  -